<DOC>
	<DOCNO>NCT01481610</DOCNO>
	<brief_summary>The purpose study determine whether use lumiracoxib particular population associate decrease glomerular filtration rate ( GFR ) compare diclofenac ; compare magnitude impairment , , associate use lumiracoxib diclofenac .</brief_summary>
	<brief_title>Safety Study Renal Function Patients With Chronic Kidney Failure Taking Lumiracoxib Diclofenac Arthralgia</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<criteria>chronic joint pain , require analgesia preexist chronic kidney injury , stage K/DOQI III ( GFR 30 59 ml/min ) stable phase CKD ( i.e . AKI , hospitalize ) without contraindication NSAID therapy sign informed consent receive NSAID 2 week prior study start history / actual PUD patient ESRD ( K/DOQI IV , V replacement therapy ) history hypersensitivity allergies treatment history / actual GI bleeding impair liver function test use ACEI / ARB</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Kidney Failure , Chronic</keyword>
	<keyword>Arthralgia</keyword>
	<keyword>NSAID</keyword>
	<keyword>Diclofenac</keyword>
	<keyword>Lumiracoxib</keyword>
	<keyword>Safety</keyword>
</DOC>